{"nct_id":"NCT02979639","title":"Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age","status":"COMPLETED","status_verified_date":"2019-09","start_date":"2017-01-16","start_date_type":"ACTUAL","primary_completion_date":"2017-04-12","primary_completion_date_type":"ACTUAL","completion_date":"2018-05-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}